EVI PLATFORM / EVICHEW

A Direct-Compression Excipient Blend for Chewable Tablets

EviChew is BELNOVA’s directly compressible excipient blend developed for chewable tablet formulations. Available with Mannitol DC and Sorbitol DC bases, the EviChew range gives formulation teams two starting points for evaluating compression behavior, tablet texture and finished-product sensory characteristics.

Compare EviChew Formulas Request an EviChew Sample

Explore the Evi Platform

Chewable
system

Two formulation pathways

Mannitol DCSorbitol DC

Product overview

What is EviChew?

EviChew is a prepared, directly compressible excipient blend developed to provide a structured foundation for chewable tablet formulation. It is intended to help manufacturers evaluate powder flow, compression, tablet texture and sensory characteristics without beginning with multiple individual excipients as separate formulation components.

EviChew is supplied without flavor. The customer adds the active ingredient and the flavor components required for the finished formulation.

Directly compressible excipient blend

Developed for chewable tablets

Available with Mannitol DC or Sorbitol DC

Supplied without flavor

Intended for formulation and manufacturing evaluation

Formula selector

Compare the two EviChew starting points.

The selector keeps the confirmed details for each formula visible and usable by keyboard, touch and mouse.

Mannitol DC base

EviChew - Mannitol DC

EviChew - Mannitol DC is a directly compressible excipient blend developed for chewable tablets where compression performance, a smooth texture and a clean sensory profile are important formulation considerations.

Formulation direction

Mannitol DC is widely used for its direct-compression behavior and clean sensory profile. Its mild sweetness, crisp mouthfeel and characteristic cooling sensation make it relevant for chewable tablets where manufacturing performance and consumer experience both require consideration.

Request an EviChew Sample

Powder flow

Compression behavior

Smooth, non-gritty chewable texture

Mild sweetness

Refreshing cooling sensation

Tablet weight and hardness consistency

Tablet durability and friability

Formulation simplicity

Formula comparison

Two directions, a shared chewable foundation.

Mannitol DC base

EviChew - Mannitol DC

Mild sweetness

Clean sensory profile

Subtle cooling sensation

Smooth, non-gritty texture

Direct-compression formulation pathway

Sorbitol DC base

EviChew - Sorbitol DC

Chewable-tablet formulation pathway

Direct-compression evaluation

Product-specific information available from BELNOVA

Shared EviChew foundation

Developed for chewable tabletsSupplied without flavorCustomer adds the active ingredientCustomer adds the desired flavorFinished formulation requires validation

Chewable formulation priorities

A connected review framework.

EviChew provides a prepared excipient starting point, while active ingredients, flavors, tooling and compression settings affect the finished product.

Powder flow

Die filling

Compression response

Tablet weight

Hardness

Friability

Texture

Mouthfeel

Taste

Active-ingredient compatibility

Stability

Scale-up behavior

Formulation pathway

From base selection to finished-tablet validation.

The pathway helps frame evaluation; it does not guarantee a commercially suitable formulation.

Select the relevant EviChew base

Add the active ingredient

Add the required flavor components

Evaluate flow and blend behavior

Compress using the selected tooling and settings

Evaluate texture and sensory characteristics

Validate the finished tablet

Applications

Developed for Chewable Tablet Applications

These are intended application directions. Technical and finished-product suitability should be evaluated in the customer’s complete formulation context.

1Chewable vitamins

2Dietary supplements

3Pharmaceutical chewable tablets

4Veterinary formulations

5Compounding pharmacies

6Product development

7Clinical formulations

Manufacturing behavior

Make the process review practical.

Powder movement

Compression

Tablet consistency

Hardness

Friability

Finished-product experience

Evaluate the sensory direction in context.

Texture

Mouthfeel

Sweetness

Cooling sensation where applicable

Flavor selection

Both manufacturing behavior and finished-product experience should be evaluated using the customer’s complete formulation.

FORMULATION NOTE

EviChew is supplied without flavor. The customer adds the active ingredient and flavor. Finished-tablet disintegration, hardness, friability, taste and stability must be validated using the customer’s complete formulation, tooling and compression settings.

Documentation and samples

Support the next evaluation step.

Product information, sample availability and available documentation can be requested from BELNOVA where applicable.

Request an EviChew sample

Request product information

Request available documentation

Discuss formulation fit

Next conversation

Evaluate the Right EviChew Base for Your Formulation

Tell BELNOVA about your active ingredients, desired texture, sensory priorities, production stage and tablet requirements. The team can help identify the most relevant EviChew pathway for evaluation.

Request an EviChew Sample Discuss Your Chewable Formulation

Return to the Evi Platform